Full name
VISUS-KAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.78.Z - Retail sale of other new products
86.21.Z - General medical practice
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | -0,1 | 0,4 | 428,9 |
EBITDA | 0,3 | 0,1 | 0,4 | 468,4 |
Short time liabilities | 0,4 | 0,4 | 0,3 | -29,6 |
Equity capital | 0,9 | 0,8 | 1,1 | 43 |
Operating profit (EBIT) | 0,2 | -0,1 | 0,4 | 428,9 |
Assets | 1,2 | 1,1 | 1,3 | 18,1 |
Net profit (loss) | 0,2 | -0,1 | 0,3 | 385,4 |
Cash | 0,5 | 0,5 | 0,7 | 37,8 |
Net income from sale | 3,5 | 4,4 | 4,9 | 10,8 |
Liabilities and provisions for liabilities | 0,4 | 0,4 | 0,3 | -30,9 |
Working assets | 1 | 1,1 | 1,3 | 19,1 |
Depreciation | 0 | 0,2 | 0 | -87,7 |
% | % | % | p.p. | |
Profitability of capital | 28,7 | -15,1 | 30,1 | 45,2 |
Equity capital to total assets | 70 | 66,3 | 80,3 | 14 |
Gross profit margin | 7,2 | -2,5 | 7,3 | 9,8 |
EBITDA Margin | 8,6 | 1,5 | 7,7 | 6,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | 31 | 20 | -11 |
Current financial liquidity indicator | 2.8176238536834717 | 2.900773286819458 | 4.9993977546691895 | 2,1 |
Net dept to EBITDA | -1.523813247680664 | -7.310261249542236 | -1.813170075416565 | 5,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane